Entos Pharmaceuticals, Inc. is developing a vaccine to prevent COVID-19 infections — and it could be ready in less than a year.
The Edmonton-based company is led by Dr. John Lewis, a University of Alberta researcher who is world-renowned for his team’s work on prostate cancer detection, progression and drug delivery.
Entos is creating a DNA-based vaccine which would protect against multiple components of the new coronavirus for “maximum protection.” Unlike a traditional vaccine which gives patients a weakened or inactive virus to provoke an immune response, Lewis said the Entos product would deliver battle instructions.